An inverse correlation between the apparent rate of dopamine clearance and tonic autoinhibition in subdomains of the rat striatum: a possible role of transporter-mediated dopamine efflux.
The dopaminergic terminal field in the rat striatum is compartmentalized into sub-domains that exhibit distinct dynamics of electrically evoked dopamine release. The fast striatal domains, where dopamine release is predominantly vesicular, exhibit conventional dopaminergic activity. However, vesicular dopamine release is tonically autoinhibited in the slow domains, which suggests that dopamine reaches the autoreceptors via a non-vesicular route. Hence, it appears that the domains use distinct mechanisms to regulate the basal dopamine concentration available to activate, or not, pre-synaptic autoinhibitory receptors. However, direct detection of local variations in tonic extracellular dopamine concentrations is not yet possible. So, the present study employed voltammetry to test the hypothesis that the apparent rate of dopamine clearance from the extracellular space should be domain-dependent. The apparent rate of dopamine clearance is equal to the difference in the rates of dopamine release and uptake that determine extracellular dopamine concentrations. This study confirms that the apparent rate of dopamine clearance is slower in the slow striatal domains where vesicular dopamine release is tonically autoinhibited. These findings support the view that the basal concentration in slow domains is maintained by a non-vesicular release process, possibly transporter-mediated efflux.
Department of Chemistry, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Keith F
KF
Moquin
Adrian C
AC
Michael
D000818:Animals; D017660:Autoreceptors / Q000378:metabolism; D003342:Corpus Striatum / Q000033:anatomy & histology* / Q000378:metabolism*; D004298:Dopamine / Q000378:metabolism*; D050483:Dopamine Plasma Membrane Transport Proteins / Q000502:physiology*; D008297:Male; D009433:Neural Inhibition / Q000502:physiology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D013572:Synaptic Vesicles / Q000378:metabolism; D013997:Time Factors
D017660:Autoreceptors; D050483:Dopamine Plasma Membrane Transport Proteins; D004298:Dopamine
J Neurosci. 2010 Sep 8;30(36):12020-7
20826665
J Neurosci. 2002 Jul 15;22(14):6272-81
12122086
Science. 1983 Jul 8;221(4606):169-71
6857277
J Neurosci. 2001 Aug 15;21(16):5916-24
11487614
Anal Chem. 2002 Feb 1;74(3):539-46
11838672
Neuroscience. 1992 Nov;51(1):55-64
1465186
J Neurochem. 1993 Dec;61(6):2269-78
8245977
Br J Pharmacol. 1971 Apr;41(4):571-91
4397129
Proc Natl Acad Sci U S A. 2005 Jul 19;102(29):10023-8
16006505
J Neurochem. 2003 Dec;87(5):1284-95
14622108
J Neurochem. 1993 Feb;60(2):527-35
8419534
J Neurochem. 2009 Sep;110(5):1491-501
19627437
J Neurophysiol. 2010 Aug;104(2):922-31
20554845
Clin Chem. 2003 Oct;49(10):1763-73
14500617
J Neurosci Methods. 2001 Dec 15;112(2):119-33
11716947
J Neurochem. 2005 Sep;94(5):1202-11
15992374
J Neurosci. 2001 Dec 1;21(23):9134-41
11717346
Naunyn Schmiedebergs Arch Pharmacol. 1987 Nov;336(5):502-7
3501841
Nature. 2003 Apr 10;422(6932):614-8
12687000
J Neurochem. 1984 Aug;43(2):560-9
6736965
J Neurochem. 2010 Jul;114(1):150-9
20403079
J Neurochem. 2004 Oct;91(1):220-9
15379902
Brain Res. 1989 May 22;487(2):311-20
2786444
J Neurosci. 2009 Feb 11;29(6):1735-42
19211880
Nat Neurosci. 2002 Oct;5(10):971-8
12352983
J Neurosci. 2004 May 5;24(18):4393-400
15128853
J Neurochem. 2005 Jan;92(1):46-58
15606895
Annu Rev Neurosci. 2007;30:259-88
17600522
J Neurochem. 1999 Jan;72(1):148-56
9886065
Neurosci Lett. 1994 Aug 1;176(2):259-63
7830960
Ann N Y Acad Sci. 1992 May 11;648:71-86
1637074
Annu Rev Neurosci. 1993;16:73-93
8096377
Neuroscience. 1989;28(3):653-61
2710338
Nat Rev Neurosci. 2003 Jan;4(1):13-25
12511858
Neuroscience. 1986 Dec;19(4):1081-90
2881227
Anal Chem. 2000 Dec 15;72(24):5994-6002
11140768
J Neurosci. 1994 Oct;14(10):6084-93
7931564
J Neurosci. 2010 Oct 20;30(42):14273-83
20962248
Neuroscience. 2000;98(4):729-41
10891616
Neuropharmacology. 2010 Mar;58(3):605-12
19951714
J Neurochem. 2000 Apr;74(4):1563-73
10737613
J Neurosci. 2004 Feb 18;24(7):1754-9
14973252
Neuroscience. 2003;118(3):819-29
12710989
Synapse. 2002 Apr;44(1):15-22
11842442
J Neurosci. 1995 Mar;15(3 Pt 1):1714-23
7534339
Eur J Neurosci. 2007 Oct;26(7):2046-54
17868375
J Neurosci. 1996 Jan 15;16(2):436-47
8551328
Naunyn Schmiedebergs Arch Pharmacol. 1997 Jun;355(6):716-9
9205955
Naunyn Schmiedebergs Arch Pharmacol. 1990 Oct;342(4):407-14
1701521
Neuroreport. 2001 Aug 8;12(11):2549-52
11496146
J Neurochem. 2007 Aug;102(4):1115-24
17663751
J Pharmacol Exp Ther. 1991 Mar;256(3):1132-8
1672376
Neurochem Int. 2001 Feb;38(2):83-106
11137879
J Neurosci Methods. 2002 Nov 15;121(1):41-52
12393160
J Neurochem. 1993 Aug;61(2):637-47
8336146
Nat Neurosci. 2003 Sep;6(9):968-73
12897785
Eur J Pharmacol. 2003 Oct 31;479(1-3):117-25
14612143
Neuroscience. 1988 May;25(2):513-23
3399057